Smaller prostate gland size and older age predict Gleason score upgrading
Objectives Gleason score is important for prostate cancer (CaP) risk stratification and
prognostication but has a significant rate of upgrading. We examined the effect of prostate …
prognostication but has a significant rate of upgrading. We examined the effect of prostate …
[HTML][HTML] Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score≤ 6
Methods: We performed a retrospective study of patients who underwent RRP for clinically
localized prostate cancer at 2 major centres between January 2007 and March 2013. All …
localized prostate cancer at 2 major centres between January 2007 and March 2013. All …
Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease
J Neuhaus, E Schiffer, P von Wilcke, HW Bauer… - PloS one, 2013 - journals.plos.org
Background Extensive prostate specific antigen screening for prostate cancer generates a
high number of unnecessary biopsies and over-treatment due to insufficient differentiation …
high number of unnecessary biopsies and over-treatment due to insufficient differentiation …
Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason≤ 6 on biopsy cores
T Seisen, F Roudot-Thoraval, PO Bosset… - World Journal of …, 2015 - Springer
Purpose Biopsy and final pathological Gleason score (GS) are inconstantly correlated with
each other. The aim of the current study was to develop and validate a predictive score to …
each other. The aim of the current study was to develop and validate a predictive score to …
[PDF][PDF] Does the time from biopsy to radical prostatectomy affect Gleason score upgrading in patients with clinical t1c prostate cancer?
M Eroglu, OG Doluoglu, H Sarici, O Telli… - Korean journal of …, 2014 - synapse.koreamed.org
Purpose: It is debated whether treatment delay worsens oncologic results in localized
prostate cancer (PCa). Few studies have focused on the role of a delay between the time of …
prostate cancer (PCa). Few studies have focused on the role of a delay between the time of …
[HTML][HTML] 前列腺癌患者根治术后病理Gleason 评分升高预测因素研究
李海斌， 敬培胜 - 2016 - aammt.tmmu.edu.cn
目的探讨经直肠前列腺穿刺活检的中低危前列腺癌患者术后发生病理Gleason
评分升高的预测因素. 方法收集2005 年1 月至2016 年5 月于我院泌尿外科接受前列腺穿刺活检 …
评分升高的预测因素. 方法收集2005 年1 月至2016 年5 月于我院泌尿外科接受前列腺穿刺活检 …
Improving the Gleason grading accuracy of transrectal ultrasound-guided biopsy
ML Nieto-Morales, J Fernandez-Ramos… - Acta …, 2013 - journals.sagepub.com
Background Transrectal ultrasound (TRUS)-guided prostate biopsy is the technique of
choice for the assessment of clinical suspicion of prostate cancer (PC) based on abnormal …
choice for the assessment of clinical suspicion of prostate cancer (PC) based on abnormal …
[PDF][PDF] Seminal Plasma as a Source of Prostate Cancer Peptide Biomarker Candidates for
J Neuhaus, E Schiffer, P von Wilcke, HW Bauer… - 2013 - academia.edu
Background: Extensive prostate specific antigen screening for prostate cancer generates a
high number of unnecessary biopsies and over-treatment due to insufficient differentiation …
high number of unnecessary biopsies and over-treatment due to insufficient differentiation …
Stellenwert der radikalen Prostatovesikulektomie bei klinisch fortgeschrittenen Prostatakarzinomen
AP Paolazzi - 2016 - oparu.uni-ulm.de
Abstract Das lokal fortgeschrittene Prostatakarzinom (PCa) ist ein klinisch relevantes
Problem. Die TNM-Klassifikation geht von T3-T4 Karzinomen aus, von denen man klinisch …
Problem. Die TNM-Klassifikation geht von T3-T4 Karzinomen aus, von denen man klinisch …
General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate …
MA Khan - BJU international, 2012 - search.ebscohost.com
GENERAL APPLICATION OF THE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL
EXCELLENCE (NICE) GUIDANCE FOR ACTIVE SURVEILLANCE FOR MEN WITH PROSTATE …
EXCELLENCE (NICE) GUIDANCE FOR ACTIVE SURVEILLANCE FOR MEN WITH PROSTATE …